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Psoriasis is a common inflammatory skin disease with
key immunological and genetic components.
Recruitment of leukocytes into the skin is a central step
in its pathogenesis, and it is mediated by cytokines.
Among the cytokines expressed in psoriatic lesions,
CCL4 and CCL4L chemokines appear to be pivotal ele-
ments for the skin recruitment of proinflammatory cells.
The aim of this study is to evaluate the relationship
between CCL4L polymorphisms [including Single
Nucleotide Polymorphisms (SNPs) and Copy Number
Variation (CNV)] and the course and prognosis of psoria-
sis. We analyzed the CNV and the rs4796195 SNP in 211
psoriatic patients and 234 controls; sera from both popu-
lations were also quantified for CCL4/CCL4L protein.
Our results showed that a high CNV (≥3 copies) is asso-
ciated with psoriasis severity, while moderate disease is
more frequent in patients with lower CNV (≤2c o p i e s ) ;
specifically CCL4L1 allele is more present in patients
with severe psoriasis, while CCL4L2 correlates with a
milder disease. In addition we found a positive correla-
tion between the CNV and sera protein levels.
Our results suggest that CCL4L genotyping could not
only allow a better understanding of the psoriatic patho-
genesis, but could also be used as a prognostic tool,
even helping to modulate the efficacy of treatments.
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